This report contains market size and forecasts of Anticoagulant Reversal Drugs in Global, including the following market information:
Global Anticoagulant Reversal Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Anticoagulant Reversal Drugs market was valued at 1486.6 million in 2021 and is projected to reach US$ 2265.2 million by 2028, at a CAGR of 6.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Prothrombin Complex Concentrates (PCC) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anticoagulant Reversal Drugs include Pfizer, Bausch Health Companies, Fresenius, Boehringer Ingelheim, Amneal Pharmaceuticals, CSL Limited, Octapharma AG, Portola Pharmaceuticals and AMAG Pharmaceuticals. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anticoagulant Reversal Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anticoagulant Reversal Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Anticoagulant Reversal Drugs Market Segment Percentages, by Type, 2021 (%)
Prothrombin Complex Concentrates (PCC)
Vitamin K
Protamine
Tranexamic Acid
Idarucizumab
Others
Global Anticoagulant Reversal Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Anticoagulant Reversal Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Anticoagulant Reversal Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Anticoagulant Reversal Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anticoagulant Reversal Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Anticoagulant Reversal Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Bausch Health Companies
Fresenius
Boehringer Ingelheim
Amneal Pharmaceuticals
CSL Limited
Octapharma AG
Portola Pharmaceuticals
AMAG Pharmaceuticals